• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疫苗接种后抗刺突抗体滴度与预防突破性严重急性呼吸综合征冠状病毒 2 感染的相关性:一项基于人群的纵向研究。

Correlation Between Postvaccination Anti-Spike Antibody Titers and Protection Against Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Population-Based Longitudinal Study.

机构信息

Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.

Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.

出版信息

J Infect Dis. 2022 Nov 28;226(11):1903-1908. doi: 10.1093/infdis/jiac321.

DOI:10.1093/infdis/jiac321
PMID:35906930
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9384605/
Abstract

In this population-based cohort of 7538 adults, combined immunoglobulin (Ig) G, IgA, and IgM (IgG/A/M) anti-spike titers measured after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination were predictive of protection against breakthrough SARS-CoV-2 infection. Discrimination was significantly improved by adjustment for factors influencing risk of SARS-CoV-2 exposure, including household overcrowding, public transport use, and visits to indoor public places. Anti-spike IgG/A/M titers showed positive correlation with neutralizing antibody titers (rs = 0.80 [95% confidence interval, .72-.86]; P < .001) and S peptide-stimulated interferon-γ concentrations (rs = 0.31 [.13-.47]; P < .001).

摘要

在这项基于人群的 7538 名成年人队列研究中,严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)疫苗接种后测量的免疫球蛋白 G(IgG)、免疫球蛋白 A(IgA)和免疫球蛋白 M(IgM)(IgG/A/M)抗刺突抗体滴度可预测对突破性 SARS-CoV-2 感染的保护作用。通过调整影响 SARS-CoV-2 暴露风险的因素(包括家庭拥挤、使用公共交通工具和室内公共场所的访问),可显著提高对 SARS-CoV-2 感染的预测效果。抗刺突 IgG/A/M 滴度与中和抗体滴度呈正相关(rs=0.80[95%置信区间,0.72-0.86];P<0.001),与 S 肽刺激的干扰素-γ浓度呈正相关(rs=0.31[0.13-0.47];P<0.001)。

相似文献

1
Correlation Between Postvaccination Anti-Spike Antibody Titers and Protection Against Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Population-Based Longitudinal Study.疫苗接种后抗刺突抗体滴度与预防突破性严重急性呼吸综合征冠状病毒 2 感染的相关性:一项基于人群的纵向研究。
J Infect Dis. 2022 Nov 28;226(11):1903-1908. doi: 10.1093/infdis/jiac321.
2
A case report of breakthrough infection with the SARS-CoV-2 delta variant and household transmission: Role of vaccination, anti-spike IgG and neutralizing activity.SARS-CoV-2 德尔塔变异株突破性感染及家庭传播病例报告:疫苗接种、抗刺突 IgG 及中和活性的作用。
J Infect Chemother. 2022 Jul;28(7):962-964. doi: 10.1016/j.jiac.2022.02.003. Epub 2022 Feb 11.
3
Long-term persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein-specific and neutralizing antibodies in recovered COVID-19 patients.康复的 COVID-19 患者中严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)刺突蛋白特异性和中和抗体的长期持久性。
PLoS One. 2022 Apr 21;17(4):e0267102. doi: 10.1371/journal.pone.0267102. eCollection 2022.
4
Response and Duration of Serum Anti-SARS-CoV-2 Antibodies After Inactivated Vaccination Within 160 Days.接种灭活疫苗后 160 天内血清抗 SARS-CoV-2 抗体的反应和持续时间。
Front Immunol. 2021 Dec 23;12:786554. doi: 10.3389/fimmu.2021.786554. eCollection 2021.
5
Are SARS-CoV-2 Antibodies Detectable in Human Milk After Vaccination Against COVID-19?接种 COVID-19 疫苗后,人乳中能否检测到 SARS-CoV-2 抗体?
J Pediatric Infect Dis Soc. 2022 Apr 30;11(4):126. doi: 10.1093/jpids/piac024.
6
Longitudinal Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Antibody Responses and Identification of Vaccine Breakthrough Infections Among Healthcare Workers Using Nucleocapsid Immunoglobulin G.利用核衣壳 IgG 对医护人员进行的纵向严重急性呼吸综合征冠状病毒 2 疫苗抗体反应和疫苗突破性感染的鉴定。
J Infect Dis. 2022 Nov 28;226(11):1934-1942. doi: 10.1093/infdis/jiac420.
7
Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine.韩国医护人员接种第二剂 BNT162b2 mRNA 疫苗 6 个月后仍保持对 SARS-CoV-2 的抗体应答。
Front Immunol. 2022 Jan 31;13:827306. doi: 10.3389/fimmu.2022.827306. eCollection 2022.
8
Factors associated with anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein antibody titer and neutralizing activity among healthcare workers following vaccination with the BNT162b2 vaccine.接种 BNT162b2 疫苗后医护人员抗严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)刺突蛋白抗体效价和中和活性的相关因素。
PLoS One. 2022 Jun 10;17(6):e0269917. doi: 10.1371/journal.pone.0269917. eCollection 2022.
9
Post-vaccination antibody evaluation for nosocomial SARS-CoV-2 delta variant breakthrough infection.疫苗接种后针对医院内 SARS-CoV-2 德尔塔变异株突破感染的抗体评估。
PLoS One. 2022 Jul 25;17(7):e0272056. doi: 10.1371/journal.pone.0272056. eCollection 2022.
10
Correlation of SARS-CoV-2 Viral Neutralizing Antibody Titers with Anti-Spike Antibodies and ACE-2 Inhibition among Vaccinated Individuals.接种疫苗人群中 SARS-CoV-2 病毒中和抗体滴度与刺突抗体和 ACE2 抑制的相关性。
Microbiol Spectr. 2022 Oct 26;10(5):e0131522. doi: 10.1128/spectrum.01315-22. Epub 2022 Sep 19.

引用本文的文献

1
SARS-Cov-2 vaccination strategies in hospitalized recovered COVID-19 patients: a randomized clinical trial (VATICO Trial).住院康复的新冠病毒肺炎患者的严重急性呼吸综合征冠状病毒2疫苗接种策略:一项随机临床试验(VATICO试验)
Sci Rep. 2025 Mar 22;15(1):9882. doi: 10.1038/s41598-025-92742-x.
2
Humoral and Innate Immunological Profile of Paediatric Recipients of Pfizer-BioNTech BNT162b2 mRNA Vaccine.辉瑞 - 生物科技公司BNT162b2 mRNA疫苗儿科接种者的体液免疫和固有免疫特征
Microorganisms. 2024 Jul 9;12(7):1389. doi: 10.3390/microorganisms12071389.
3
IgG and IgM differentiation in a particle-based agglutination assay by control over antigen surface density.通过控制抗原表面密度在基于颗粒的凝集试验中进行IgG和IgM鉴别。
APL Bioeng. 2024 Jun 13;8(2):026124. doi: 10.1063/5.0196224. eCollection 2024 Jun.
4
Influence of individuals' determinants including vaccine type on cellular and humoral responses to SARS-CoV-2 vaccination.包括疫苗类型在内的个体决定因素对新冠病毒疫苗接种的细胞和体液反应的影响。
NPJ Vaccines. 2024 May 22;9(1):87. doi: 10.1038/s41541-024-00878-0.
5
Immune and behavioral correlates of protection against symptomatic post-vaccination SARS-CoV-2 infection.免疫和行为因素与接种疫苗后预防有症状的 SARS-CoV-2 感染的相关性。
Front Immunol. 2024 Mar 19;15:1287504. doi: 10.3389/fimmu.2024.1287504. eCollection 2024.
6
Impact of the COVID-19 vaccine booster strategy on vaccine protection: a pilot study of a military hospital in Taiwan.新冠疫苗加强针策略对疫苗保护效果的影响:台湾某军队医院的一项试点研究。
Clin Exp Vaccine Res. 2023 Oct;12(4):337-345. doi: 10.7774/cevr.2023.12.4.337. Epub 2023 Oct 31.
7
Correlates of protection against COVID-19 infection and intensity of symptomatic disease in vaccinated individuals exposed to SARS-CoV-2 in households in Israel (ICoFS): a prospective cohort study.在以色列家庭中暴露于 SARS-CoV-2 的接种个体中 COVID-19 感染和症状性疾病严重程度的保护相关性(ICoFS):一项前瞻性队列研究。
Lancet Microbe. 2023 May;4(5):e309-e318. doi: 10.1016/S2666-5247(23)00012-5. Epub 2023 Mar 21.
8
Use of Hu-PBL Mice to Study Pathogenesis of Human-Restricted Viruses.利用 Hu-PBL 小鼠研究人类局限性病毒的发病机制。
Viruses. 2023 Jan 13;15(1):228. doi: 10.3390/v15010228.
9
Durable CD8 T Cell Memory against SARS-CoV-2 by Prime/Boost and Multi-Dose Vaccination: Considerations on Inter-Dose Time Intervals.通过加强免疫和多剂量疫苗接种产生针对 SARS-CoV-2 的持久 CD8 T 细胞记忆:关于剂量间隔时间的考虑。
Int J Mol Sci. 2022 Nov 19;23(22):14367. doi: 10.3390/ijms232214367.
10
Rebound in asthma exacerbations following relaxation of COVID-19 restrictions: a longitudinal population-based study (COVIDENCE UK).COVID-19 限制放松后哮喘恶化的反弹:一项基于人群的纵向研究(COVIDENCE UK)。
Thorax. 2023 Aug;78(8):752-759. doi: 10.1136/thorax-2022-219591. Epub 2022 Nov 23.